|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/29/24 Organicell Regenerative Medi… Inc 10-K 10/31/23 73:7.7M Empire Filings/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.81M
2: EX-23.1(A) Consent of Expert or Counsel HTML 19K
3: EX-23.1(B) Consent of Expert or Counsel HTML 19K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 20K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 20K
13: R1 Cover HTML 85K
14: R2 Consolidated Balance Sheets HTML 123K
15: R3 Consolidated Balance Sheets (Parenthetical) HTML 40K
16: R4 Consolidated Statements of Operations HTML 90K
17: R5 Consolidated Statements of Operations HTML 21K
(Parenthetical)
18: R6 Consolidated Changes to Stockholders' Equity HTML 89K
(Deficit)
19: R7 Consolidated Statements of Cash Flows HTML 140K
20: R8 Organization and Description of Business HTML 26K
21: R9 Summary of Significant Accounting Policies HTML 76K
22: R10 Going Concern HTML 29K
23: R11 Restructuring HTML 33K
24: R12 Inventories HTML 26K
25: R13 Property and Equipment HTML 38K
26: R14 Equity in Non-Marketable Securities of Affiliated HTML 30K
Entity
27: R15 Lease Obligations HTML 43K
28: R16 Related Party Transactions HTML 37K
29: R17 Accounts Payable and Accrued Expenses HTML 30K
30: R18 Notes Payable HTML 65K
31: R19 Income Taxes HTML 73K
32: R20 Capital Stock HTML 119K
33: R21 Warrants HTML 152K
34: R22 Commitments and Contingencies HTML 87K
35: R23 Segment Information HTML 26K
36: R24 Summary of Significant Accounting Policies HTML 122K
(Policies)
37: R25 Inventories (Tables) HTML 26K
38: R26 Property and Equipment (Tables) HTML 31K
39: R27 Equity in Non-Marketable Securities of Affiliated HTML 25K
Entity (Tables)
40: R28 Lease Obligations (Tables) HTML 27K
41: R29 Accounts Payable and Accrued Expenses (Tables) HTML 30K
42: R30 Notes Payable (Tables) HTML 26K
43: R31 Income Taxes (Tables) HTML 65K
44: R32 Capital Stock (Tables) HTML 43K
45: R33 Warrants (Tables) HTML 72K
46: R34 Summary of Significant Accounting Policies HTML 93K
(Details Narrative)
47: R35 Going Concern (Details Narrative) HTML 46K
48: R36 Restructuring (Details Narrative) HTML 44K
49: R37 Inventories (Details) HTML 26K
50: R38 Property and Equipment (Details) HTML 37K
51: R39 Property and Equipment (Details Narrative) HTML 41K
52: R40 Equity in Non-Marketable Securities of Affiliated HTML 24K
Entity (Details)
53: R41 Lease Obligations (Details) HTML 38K
54: R42 Lease Obligations (Details Narrative) HTML 75K
55: R43 Related Party Transactions (Details Narrative) HTML 61K
56: R44 Accounts Payable and Accrued Expenses (Details) HTML 37K
57: R45 Notes Payable (Details) HTML 29K
58: R46 Notes Payable (Details Narrative) HTML 159K
59: R47 Income Taxes (Details) HTML 44K
60: R48 Income Taxes (Details 1) HTML 39K
61: R49 Income Taxes (Details 2) HTML 41K
62: R50 Income Taxes (Details Narrative) HTML 31K
63: R51 Capital Stock (Details) HTML 36K
64: R52 Capital Stock (Details Narrative) HTML 235K
65: R53 Warrants (Details) HTML 65K
66: R54 Warrants (Details Narrative) HTML 163K
67: R55 Commitments and Contingencies (Details Narrative) HTML 154K
68: R56 Segment Information (Details Narrative) HTML 22K
70: XML IDEA XML File -- Filing Summary XML 124K
73: XML XBRL Instance -- organicellregen_10k_htm XML 1.53M
69: EXCEL IDEA Workbook of Financial Report Info XLSX 171K
9: EX-101.CAL XBRL Calculations -- ocel-20231031_cal XML 197K
10: EX-101.DEF XBRL Definitions -- ocel-20231031_def XML 607K
11: EX-101.LAB XBRL Labels -- ocel-20231031_lab XML 1.05M
12: EX-101.PRE XBRL Presentations -- ocel-20231031_pre XML 887K
8: EX-101.SCH XBRL Schema -- ocel-20231031 XSD 209K
71: JSON XBRL Instance as JSON Data -- MetaLinks 435± 607K
72: ZIP XBRL Zipped Folder -- 0001829126-24-000541-xbrl Zip 477K
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned Ian T. Bothwell, Chief Financial Officer (principal financial and accounting officer) of Organicell Regenerative Medicine, Inc., a Nevada corporation (the “Company”), hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | the Annual Report on Form 10-K of the Company for the fiscal year ended October 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. |
| Date: January 29, 2024 | /s/ Ian T. Bothwell |
| Ian T. Bothwell | |
| Chief Financial Officer | |
| (Principal Financial and Accounting Officer) |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 1/29/24 | None on these Dates | ||
| For Period end: | 10/31/23 | |||
| List all Filings | ||||